Huaren Pharmaceutical Co Ltd (300110) — Cash Flow Reinvestment Rate
Huaren Pharmaceutical Co Ltd (300110) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥7.00 Million (capex CN¥7.00 Million ) from operating cash flow of CN¥86.78 Million. See Huaren Pharmaceutical Co Ltd (300110) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Huaren Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Huaren Pharmaceutical Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see Huaren Pharmaceutical Co Ltd (300110) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Huaren Pharmaceutical Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Huaren Pharmaceutical Co Ltd. See Huaren Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥49.34 Million | CN¥390.23 Million | CN¥48.98 Million | ▲ +62.3% |
| 2024 | 0.08x | CN¥25.11 Million | CN¥322.36 Million | CN¥24.69 Million | ▼ -48.4% |
| 2023 | 0.15x | CN¥46.16 Million | CN¥305.60 Million | CN¥45.86 Million | ▼ -82.3% |
| 2022 | 0.85x | CN¥186.14 Million | CN¥217.98 Million | CN¥42.33 Million | ▲ +657.5% |
| 2019 | 0.11x | CN¥34.87 Million | CN¥309.33 Million | CN¥32.02 Million | ▼ -49.3% |
| 2018 | 0.22x | CN¥56.58 Million | CN¥254.32 Million | CN¥45.47 Million | ▼ -55.0% |
| 2017 | 0.49x | CN¥104.47 Million | CN¥211.08 Million | CN¥87.36 Million | ▼ -73.3% |
| 2016 | 1.86x | CN¥337.17 Million | CN¥181.65 Million | CN¥168.95 Million | ▼ -80.0% |
| 2015 | 9.26x | CN¥173.84 Million | CN¥18.77 Million | CN¥156.73 Million | ▲ +133.8% |
| 2014 | 3.96x | CN¥259.80 Million | CN¥65.56 Million | CN¥259.80 Million | ▼ -30.8% |
| 2013 | 5.72x | CN¥227.69 Million | CN¥39.78 Million | CN¥227.69 Million | ▲ +110.5% |
| 2012 | 2.72x | CN¥270.43 Million | CN¥99.44 Million | CN¥270.43 Million | ▼ -30.5% |
| 2011 | 3.91x | CN¥232.83 Million | CN¥59.53 Million | CN¥232.83 Million | ▲ +352.4% |
| 2010 | 0.86x | CN¥67.10 Million | CN¥77.61 Million | CN¥67.10 Million | ▼ -65.7% |
| 2009 | 2.52x | CN¥97.25 Million | CN¥38.63 Million | CN¥97.25 Million | ▲ +10.2% |
| 2008 | 2.29x | CN¥130.82 Million | CN¥57.24 Million | CN¥130.82 Million | ▲ +97.7% |
| 2007 | 1.16x | CN¥8.86 Million | CN¥7.66 Million | CN¥8.86 Million | — |